Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis.

Ashizawa N, Miyazaki T, Abe S, Takazono T, Saijo T, Obata Y, Shimamura S, Yamamoto K, Imamura Y, Koji T, Nishino T, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Sci Rep. 2019 Jun 27;9(1):9331. doi: 10.1038/s41598-019-45776-x.

2.

The Novel Arylamidine T-2307 Selectively Disrupts Yeast Mitochondrial Function by Inhibiting Respiratory Chain Complexes.

Yamashita K, Miyazaki T, Fukuda Y, Mitsuyama J, Saijo T, Shimamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00374-19. doi: 10.1128/AAC.00374-19. Print 2019 Aug.

3.

The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia in elderly patients: A randomized, multicenter, open-label trial.

Miyazaki T, Nakamura S, Hashiguchi K, Kobayashi T, Fukushima K, Fukuda Y, Kondo A, Inoue Y, Koga H, Sasaki E, Nagayoshi Y, Higashiyama Y, Yoshida M, Takazono T, Saijo T, Morinaga Y, Yamamoto K, Imamura Y, Mikushi S, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

J Infect Chemother. 2019 May 18. pii: S1341-321X(19)30128-X. doi: 10.1016/j.jiac.2019.04.019. [Epub ahead of print]

4.

Efficacy and safety of cefditoren pivoxil for exacerbations of chronic obstructive pulmonary disease: A prospective multicenter interventional study.

Miyazaki T, Fukushima K, Hashiguchi K, Inoue Y, Mihara T, Sawai T, Suyama N, Kobayashi T, Kondo A, Fukuda Y, Harada Y, Sasaki E, Kaku N, Ide S, Takazono T, Saijo T, Kosai K, Morinaga Y, Nakamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

J Infect Chemother. 2019 Sep;25(9):702-707. doi: 10.1016/j.jiac.2019.03.018. Epub 2019 Apr 11.

5.

Selection of oral antifungals for initial maintenance therapy in chronic pulmonary aspergillosis: A longitudinal analysis.

Tashiro M, Takazono T, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Kakeya H, Ando T, Ogawa K, Kishi K, Tokimatsu I, Hayashi Y, Fujiuchi S, Yanagihara K, Miyazaki Y, Ichihara K, Mukae H, Kohno S, Izumikawa K.

Clin Infect Dis. 2019 Apr 9. pii: ciz287. doi: 10.1093/cid/ciz287. [Epub ahead of print]

PMID:
30959519
6.

Evaluation of Aspergillus-Specific Lateral-Flow Device Test Using Serum and Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.

Takazono T, Ito Y, Tashiro M, Nishimura K, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e00095-19. doi: 10.1128/JCM.00095-19. Print 2019 May.

PMID:
30842231
7.

Autophagy-Inducing Factor Atg1 Is Required for Virulence in the Pathogenic Fungus Candida glabrata.

Shimamura S, Miyazaki T, Tashiro M, Takazono T, Saijo T, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Front Microbiol. 2019 Jan 25;10:27. doi: 10.3389/fmicb.2019.00027. eCollection 2019.

8.

Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients.

Takazono T, Saijo T, Ashizawa N, Oshima K, Nishimura K, Tashiro M, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K, Sheppard DC.

Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):735-741. doi: 10.1007/s10096-019-03469-3. Epub 2019 Jan 25.

PMID:
30684164
9.

Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata.

Minematsu A, Miyazaki T, Shimamura S, Nishikawa H, Nakayama H, Takazono T, Saijo T, Yamamoto K, Imamura Y, Yanagihara K, Kohno S, Mukae H, Izumikawa K.

PLoS One. 2019 Jan 23;14(1):e0210883. doi: 10.1371/journal.pone.0210883. eCollection 2019.

10.

A case of bilateral emphysematous pyelonephritis caused by Candida albicans.

Ideguchi S, Yamamoto K, Ikeda A, Hashimoto K, Takazono T, Saijo T, Imamura Y, Miyazaki T, Mukae H.

J Infect Chemother. 2019 Apr;25(4):302-306. doi: 10.1016/j.jiac.2018.10.011. Epub 2018 Nov 15. Review.

PMID:
30448360
11.

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas aeruginosa.

Kosai K, Kaku N, Uno N, Saijo T, Morinaga Y, Imamura Y, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K.

Open Microbiol J. 2018 Sep 28;12:321-322. doi: 10.2174/1874285801812010321. eCollection 2018. No abstract available.

12.

Enhanced angiotensinogen expression in neonates during kidney development.

Shono M, Urushihara M, Suga K, Watanabe N, Saijo T, Nakagawa R, Kagami S.

Clin Exp Nephrol. 2019 Apr;23(4):537-543. doi: 10.1007/s10157-018-1662-3. Epub 2018 Oct 23.

PMID:
30353264
13.

[Thymoma Showing Elevating Anti-acetylcholine Receptor Antibody without Clinical Symptoms of Myasthenia Gravis;Report of a Case].

Ito T, Ishizumi T, Kataba H, Saijo T, Ikeda N.

Kyobu Geka. 2018 Aug;71(8):634-636. Japanese.

PMID:
30185764
14.

Primary Oral Mucormycosis Due to Rhizopus microsporus after Allogeneic Stem Cell Transplantation.

Sakamoto H, Itonaga H, Sawayama Y, Taguchi J, Saijo T, Kuwatsuka S, Hashisako M, Kinoshita N, Oishi M, Doi H, Kosai K, Nishimoto K, Tanaka K, Yanagihara K, Mukae H, Izumikawa K, Miyazaki Y.

Intern Med. 2018;57(17):2567-2571. doi: 10.2169/internalmedicine.0474-17. Epub 2018 Sep 1.

15.

Examining Japanese women's preferences for a new style of postnatal care facility and its attributes.

Shen J, Nakashima T, Karasawa I, Furui T, Morishige K, Saijo T.

Int J Health Plann Manage. 2018 Oct;33(4):890-901. doi: 10.1002/hpm.2544. Epub 2018 May 21.

PMID:
29781211
16.

[The current situation and agendas in the prevention and control of non-communicable diseases in Vietnam].

Hattori K, Uda H, Hitomi Y, Yano R, Saijo T, Watanabe N, Satomi M, Yoshida A, Oishi O, Yamashita T, Kamenosono A.

Nihon Koshu Eisei Zasshi. 2018;65(4):170-178. doi: 10.11236/jph.65.4_170. Japanese.

17.

Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati.

Hirayama T, Miyazaki T, Yamagishi Y, Mikamo H, Ueda T, Nakajima K, Takesue Y, Higashi Y, Yamamoto Y, Kimura M, Araoka H, Taniguchi S, Fukuda Y, Matsuo Y, Furutani A, Yamashita K, Takazono T, Saijo T, Shimamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02528-17. doi: 10.1128/AAC.02528-17. Print 2018 Jun.

18.

Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia.

Tashiro M, Fushimi K, Kawano K, Takazono T, Saijo T, Yamamoto K, Kurihara S, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

BMC Pulm Med. 2017 Dec 29;17(1):219. doi: 10.1186/s12890-017-0566-4.

19.

Comparison of Efficacy of Antimicrobial Agents Among Hospitalized Patients With Mycoplasma pneumoniae Pneumonia in Japan During Large Epidemics of Macrolide-Resistant M. pneumoniae Infections: A Nationwide Observational Study.

Tashiro M, Fushimi K, Kawano K, Takazono T, Saijo T, Yamamoto K, Kurihara S, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

Clin Infect Dis. 2017 Nov 13;65(11):1837-1842. doi: 10.1093/cid/cix695.

PMID:
29020161
20.

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa.

Kosai K, Kaku N, Uno N, Saijo T, Morinaga Y, Imamura Y, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K.

Open Microbiol J. 2017 May 31;11:92-97. doi: 10.2174/1874285801711010092. eCollection 2017.

21.

Examination of Dose Reduction Using Image Noise Reduction Technology in Cardiovascular X-ray Systems.

Saijo T, Seguchi S.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(6):451-459. doi: 10.6009/jjrt.2017_JSRT_73.6.451. Japanese.

22.

Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study.

Jayaram-Lindström N, Guterstam J, Häggkvist J, Ericson M, Malmlöf T, Schilström B, Halldin C, Cervenka S, Saijo T, Nordström AL, Franck J.

Transl Psychiatry. 2017 Apr 25;7(4):e1104. doi: 10.1038/tp.2017.79.

23.

Examination of cryptococcal glucuronoxylomannan antigen in bronchoalveolar lavage fluid for diagnosing pulmonary cryptococcosis in HIV-negative patients.

Oshima K, Takazono T, Saijo T, Tashiro M, Kurihara S, Yamamoto K, Imamura Y, Miyazaki T, Tsukamoto M, Yanagihara K, Mukae H, Kohno S, Izumikawa K.

Med Mycol. 2018 Jan 1;56(1):88-94. doi: 10.1093/mmy/myx010.

PMID:
28419364
24.

A case series of histoplasmosis patients with elevated serum soluble interleukin-2 receptor levels.

Hirayama T, Takazono T, Iwata K, Senju H, Shimazaki T, Tashiro M, Saijo T, Tanaka T, Nakamura S, Imamura Y, Kojiro M, Miyazaki T, Tsukamoto M, Furumoto A, Morimoto K, Muraosa Y, Matsubara Y, Yanagihara K, Mukae H, Kamei K, Kohno S, Izumikawa K.

J Infect Chemother. 2017 Sep;23(9):642-647. doi: 10.1016/j.jiac.2017.03.006. Epub 2017 Apr 8.

PMID:
28395939
25.

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.

Nishikawa H, Fukuda Y, Mitsuyama J, Tashiro M, Tanaka A, Takazono T, Saijo T, Yamamoto K, Nakamura S, Imamura Y, Miyazaki T, Kakeya H, Yamamoto Y, Yanagihara K, Mukae H, Kohno S, Izumikawa K.

J Antimicrob Chemother. 2017 Jun 1;72(6):1709-1713. doi: 10.1093/jac/dkx020.

26.

Negotiating with the future: incorporating imaginary future generations into negotiations.

Kamijo Y, Komiya A, Mifune N, Saijo T.

Sustain Sci. 2017;12(3):409-420. doi: 10.1007/s11625-016-0419-8. Epub 2016 Dec 30.

27.

Strategies for Utilizing Neuroimaging Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report.

Suhara T, Chaki S, Kimura H, Furusawa M, Matsumoto M, Ogura H, Negishi T, Saijo T, Higuchi M, Omura T, Watanabe R, Miyoshi S, Nakatani N, Yamamoto N, Liou SY, Takado Y, Maeda J, Okamoto Y, Okubo Y, Yamada M, Ito H, Walton NM, Yamawaki S.

Int J Neuropsychopharmacol. 2017 Apr 1;20(4):285-294. doi: 10.1093/ijnp/pyw111. Review.

28.

(Pro)renin and (pro)renin receptor expression during kidney development in neonates.

Terada T, Urushihara M, Saijo T, Nakagawa R, Kagami S.

Eur J Pediatr. 2017 Feb;176(2):183-189. doi: 10.1007/s00431-016-2820-9. Epub 2016 Dec 19.

PMID:
27995362
29.

Recurrent Streptococcus agalactiae Toxic Shock Syndrome Triggered by a Tumor Necrosis Factor-α Inhibitor.

Yoshida M, Takazono T, Tashiro M, Saijo T, Morinaga Y, Yamamoto K, Nakamura S, Imamura Y, Miyazaki T, Sawai T, Nishino T, Izumikawa K, Yanagihara K, Mukae H, Kohno S.

Intern Med. 2016;55(21):3211-3214. Epub 2016 Nov 1.

30.

Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment.

Takazono T, Sawai T, Tashiro M, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Suyama N, Izumikawa K, Kakeya H, Yanagihara K, Mukae H, Kohno S.

Intern Med. 2016;55(19):2877-2880. Epub 2016 Oct 1.

31.

Correction: Kwon-Chung, K.J. et al. Is Cryptococcus gattii a Primary Pathogen? J. Fungi 2015, 1, 154-167.

Kwon-Chung KJ, Saijo T.

J Fungi (Basel). 2016 Jul 5;2(3). pii: E20. doi: 10.3390/jof2030020.

32.

Pulmonary Nocardiosis Caused by Nocardia concava with a Literature Review.

Hirayama T, Takazono T, Horai Y, Tashiro M, Saijo T, Kosai K, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M, Izumikawa K, Yanagihara K, Kawakami A, Kohno S.

Intern Med. 2016;55(9):1213-7. doi: 10.2169/internalmedicine.55.6228. Epub 2016 May 1.

33.

The world first two cases of severe fever with thrombocytopenia syndrome: An epidemiological study in Nagasaki, Japan.

Kurihara S, Satoh A, Yu F, Hayasaka D, Shimojima M, Tashiro M, Saijo T, Takazono T, Imamura Y, Miyazaki T, Tsukamoto M, Yanagihara K, Mukae H, Saijo M, Morita K, Kohno S, Izumikawa K.

J Infect Chemother. 2016 Jul;22(7):461-5. doi: 10.1016/j.jiac.2016.04.001. Epub 2016 Apr 30.

PMID:
27142979
34.

Neuroleptic-induced deficit syndrome in bipolar disorder with psychosis.

Ueda S, Sakayori T, Omori A, Fukuta H, Kobayashi T, Ishizaka K, Saijo T, Okubo Y.

Neuropsychiatr Dis Treat. 2016 Feb 2;12:265-8. doi: 10.2147/NDT.S99577. eCollection 2016.

35.

Evaluation of Entrance Skin Dose during Catheter Ablation Procedures by Use of Reference Air-Kerma Displayed on Angiography Systems.

Seguchi S, Saijo T, Ishikawa Y, Nagao T.

Pacing Clin Electrophysiol. 2016 Mar;39(3):235-40. doi: 10.1111/pace.12790. Epub 2016 Jan 12.

PMID:
26643408
36.

The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria.

Takeda K, Imamura Y, Takazono T, Yoshida M, Ide S, Hirano K, Tashiro M, Saijo T, Kosai K, Morinaga Y, Nakamura S, Kurihara S, Tsukamoto M, Miyazaki T, Tashiro T, Kohno S, Yanagihara K, Izumikawa K.

Med Mycol. 2016 Feb;54(2):120-7. doi: 10.1093/mmy/myv093. Epub 2015 Nov 3.

PMID:
26531100
37.

Quantification of central substance P receptor occupancy by aprepitant using small animal positron emission tomography.

Endo T, Saijo T, Haneda E, Maeda J, Tokunaga M, Zhang MR, Kannami A, Asai H, Suzuki M, Suhara T, Higuchi M.

Int J Neuropsychopharmacol. 2014 Oct 31;18(2). pii: pyu030. doi: 10.1093/ijnp/pyu030.

38.

Is Cryptococcus gattii a Primary Pathogen?

Kwon-Chung KJ, Saijo T.

J Fungi (Basel). 2015;1(2):154-167. Epub 2015 Jul 29. Erratum in: J Fungi (Basel). 2016 Jul 05;2(3):.

39.

Occult hepatitis B virus infection in hemodialysis patients in Japan.

Saijo T, Joki N, Inishi Y, Muto M, Saijo M, Hase H.

Ther Apher Dial. 2015 Apr;19(2):125-30. doi: 10.1111/1744-9987.12241. Epub 2014 Nov 3.

PMID:
25363685
40.

Urinary angiotensinogen level is increased in preterm neonates.

Suzue M, Urushihara M, Nakagawa R, Saijo T, Kagami S.

Clin Exp Nephrol. 2015 Apr;19(2):293-7. doi: 10.1007/s10157-014-0977-y. Epub 2014 May 3.

PMID:
24792728
41.

Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.

Saijo T, Chen J, Chen SC, Rosen LB, Yi J, Sorrell TC, Bennett JE, Holland SM, Browne SK, Kwon-Chung KJ.

MBio. 2014 Mar 18;5(2):e00912-14. doi: 10.1128/mBio.00912-14.

42.

Phosphodiesterase 10A PET radioligand development program: from pig to human.

Plisson C, Weinzimmer D, Jakobsen S, Natesan S, Salinas C, Lin SF, Labaree D, Zheng MQ, Nabulsi N, Marques TR, Kapur S, Kawanishi E, Saijo T, Gunn RN, Carson RE, Rabiner EA.

J Nucl Med. 2014 Apr;55(4):595-601. doi: 10.2967/jnumed.113.131409. Epub 2014 Mar 10.

43.

Impact of specialization in gynecology and obstetrics departments on pregnant women's choice of maternity institutions.

Adachi Y, Iso H, Shen J, Ban K, Fukui O, Hashimoto H, Nakashima T, Morishige K, Saijo T.

Health Econ Rev. 2013 Dec 23;3(1):31. doi: 10.1186/2191-1991-3-31.

44.

Development of a tightly regulated and highly responsive copper-inducible gene expression system and its application to control of flowering time.

Saijo T, Nagasawa A.

Plant Cell Rep. 2014 Jan;33(1):47-59. doi: 10.1007/s00299-013-1511-5. Epub 2013 Oct 6.

PMID:
24097281
45.

Factors required for activation of urease as a virulence determinant in Cryptococcus neoformans.

Singh A, Panting RJ, Varma A, Saijo T, Waldron KJ, Jong A, Ngamskulrungroj P, Chang YC, Rutherford JC, Kwon-Chung KJ.

MBio. 2013 May 7;4(3):e00220-13. doi: 10.1128/mBio.00220-13.

46.

Presynaptic selectivity of a ligand for serotonin 1A receptors revealed by in vivo PET assays of rat brain.

Saijo T, Maeda J, Okauchi T, Maeda J, Morio Y, Kuwahara Y, Suzuki M, Goto N, Fukumura T, Suhara T, Higuchi M.

PLoS One. 2012;7(8):e42589. doi: 10.1371/journal.pone.0042589. Epub 2012 Aug 7.

47.

A cost-benefit analysis on the specialization in departments of obstetrics and gynecology in Japan.

Shen J, Fukui O, Hashimoto H, Nakashima T, Kimura T, Morishige K, Saijo T.

Health Econ Rev. 2012 Mar 27;2(1):2. doi: 10.1186/2191-1991-2-2.

48.

Multidetector-row computed tomography evaluation of bilateral bronchial narrowing associated with increased pulmonary blood flow in children with congenital heart disease.

Watanabe N, Hayabuchi Y, Nakagawa R, Saijo T, Kagami S.

Congenit Heart Dis. 2012 Sep-Oct;7(5):410-6. doi: 10.1111/j.1747-0803.2012.00653.x. Epub 2012 Apr 12.

PMID:
22494607
49.

Functional characterization of the regulators of calcineurin in Candida glabrata.

Miyazaki T, Izumikawa K, Nagayoshi Y, Saijo T, Yamauchi S, Morinaga Y, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Miyazaki Y, Kohno S.

FEMS Yeast Res. 2011 Dec;11(8):621-30. doi: 10.1111/j.1567-1364.2011.00751.x. Epub 2011 Sep 19.

50.

Supplemental Content

Support Center